CJC-1295 5mg without DAC + Ipamorelin 5mg
Here’s the CJC-1295 No DAC + Ipamorelin description rebuilt to match your format, with the depth and structure consistent with your other listings:
CJC-1295 (No DAC) / Ipamorelin Blend (RUO) | High Purity ≥99% | Research Grade
Product Specifications
| Specification | Details |
|---|---|
| Product Name | CJC-1295 (No DAC) / Ipamorelin Blend |
| Peptide Type | GHRH Analog + Selective Ghrelin Receptor Agonist |
| CJC-1295 (No DAC) CAS | 863288-34-0 |
| Ipamorelin CAS | 170851-70-4 |
| Purity | ≥99% (HPLC Verified) |
| Form | Lyophilized Powder |
| Solubility | Sterile Water or Bacteriostatic Water |
| Storage | −20°C, Protected from Light and Moisture |
What Is CJC-1295 (No DAC) / Ipamorelin?
CJC-1295 (No DAC) / Ipamorelin is a research blend combining two well-characterized growth hormone secretagogues and is supplied exclusively for laboratory and preclinical research applications. Each component targets a distinct receptor pathway, making this combination widely referenced in peptide research literature for studying pulsatile growth hormone (GH) release and downstream secretagogue signaling.
CJC-1295 (No DAC) is a modified synthetic analog of Growth Hormone-Releasing Hormone (GHRH) that omits the Drug Affinity Complex, resulting in a shorter half-life and a physiologically patterned, pulse-based GH release profile suited for controlled experimental studies. Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist characterized in research literature for its targeted GH stimulation without significant co-stimulation of cortisol or prolactin — a profile that distinguishes it from less selective secretagogues.
Together, these two peptides operate through complementary and synergistic mechanisms — GHRH receptor activation via CJC-1295 (No DAC) and ghrelin receptor activation via Ipamorelin — making this blend a practical tool for researchers investigating dual-pathway GH secretagogue models.
This product is clearly labeled and distributed strictly as a Research Use Only (RUO) material and is not approved for human or veterinary use.
Experimental Research Applications
In scientific literature, CJC-1295 (No DAC) and Ipamorelin have been investigated individually and in combination in a variety of experimental settings, including:
- Pulsatile growth hormone secretion and GH axis regulation research
- GHRH receptor signaling pathway studies
- Ghrelin receptor (GHS-R1a) agonism and downstream signaling research
- IGF-1 axis and somatotropic pathway investigations
- Metabolic regulation and energy homeostasis models
- Muscle and connective tissue biology research
- Sleep-associated GH pulse characterization studies
- Comparative secretagogue pathway research
These studies are conducted exclusively within laboratory and preclinical environments and are intended for mechanistic and observational research purposes.
Purity and Quality Control
Each batch of CJC-1295 (No DAC) / Ipamorelin undergoes analytical testing to ensure:
✔ ≥99% purity verified by HPLC
✔ Identity and molecular weight confirmed for each component
✔ Batch-to-batch consistency
✔ Professional documentation and traceability
✔ Controlled manufacturing standards
✔ Reliable performance for repeatable research applications
High analytical purity and strict quality control procedures help provide researchers with confidence in the consistency and reliability of each batch.
Key Research Features
- Dual-mechanism secretagogue blend — GHRH + ghrelin receptor pathways
- CJC-1295 (No DAC): short half-life, pulsatile GH release profile
- Ipamorelin: selective GHS-R1a agonist, minimal cortisol/prolactin co-stimulation
- ≥99% HPLC-verified purity
- Identity confirmed for each component
- Lyophilized powder format
- Suitable for in vitro and preclinical research
- Batch-tested for consistency
- Research-grade manufacturing standards
- Professionally labeled and documented
Storage Recommendations
To maintain product stability and research integrity, CJC-1295 (No DAC) / Ipamorelin should be:
- Stored at −20°C in a tightly sealed container
- Protected from light and moisture
- Reconstituted in sterile or bacteriostatic water
- Kept sealed until use
- Handled according to standard laboratory procedures
- Not subjected to repeated freeze-thaw cycles
Toxicology and Regulatory Information
- Each component evaluated in preclinical endocrinology and secretagogue research models
- Ipamorelin characterized in research literature for selectivity — no significant cortisol or prolactin co-stimulation reported
- CJC-1295 (No DAC) characterized for short-acting, pulsatile GH release profile without DAC-mediated receptor binding
- Supplied strictly as a Research Use Only (RUO) material
Why Choose Summit Pep Labs?
At Summit Pep Labs, we are committed to supplying researchers with premium-quality compounds manufactured to rigorous analytical standards.
Why Researchers Choose Summit Pep Labs
- ≥99% HPLC-verified purity
- Identity confirmed for each component in the blend
- Batch consistency and traceability
- Professional labeling and packaging
- Research-grade manufacturing standards
- Secure shipping and quality assurance
- Commitment to reproducibility and reliability
Frequently Asked Questions
What is CJC-1295 (No DAC) / Ipamorelin?
CJC-1295 (No DAC) / Ipamorelin is a research blend of two growth hormone secretagogues operating through complementary receptor pathways — GHRH receptor activation and ghrelin receptor (GHS-R1a) agonism — commonly referenced in scientific literature for pulsatile GH secretion and somatotropic axis research.
What is the difference between CJC-1295 with DAC and without DAC?
The Drug Affinity Complex (DAC) extends the half-life of CJC-1295 by enabling albumin binding, resulting in a prolonged, continuous GH elevation profile. The No DAC version has a shorter half-life, producing a pulsatile GH release pattern more closely resembling physiological secretion rhythms — a distinction that is meaningful for researchers studying natural GH pulse dynamics.
What makes Ipamorelin distinct from other ghrelin receptor agonists?
Ipamorelin is characterized in research literature for its selectivity at the GHS-R1a receptor with minimal co-stimulation of cortisol, prolactin, or ACTH compared to less selective secretagogues such as GHRP-2 and GHRP-6. This selectivity makes it a cleaner model compound for isolating GH-specific secretagogue pathways.
Is CJC-1295 (No DAC) / Ipamorelin approved for human use?
No. This blend is not approved by the FDA for human or veterinary use. It is supplied exclusively for research purposes.
What purity does Summit Pep Labs provide?
Each batch is tested and verified to contain ≥99% purity using HPLC analytical methods, with identity confirmation for each component.
How is this product supplied?
CJC-1295 (No DAC) / Ipamorelin is supplied as a lyophilized powder and packaged according to professional research standards.
How should it be stored?
For optimal stability and research integrity, this blend should be stored at −20°C in a tightly sealed container, protected from light and moisture, and not subjected to repeated freeze-thaw cycles. Reconstitute with sterile or bacteriostatic water.
References
- Jetté L et al. J Endocrinol. 2005;184(2):407–16 — CJC-1295 pharmacokinetics and GH release
- Raun K et al. Eur J Endocrinol. 1998;139(5):552–61 — Ipamorelin selectivity and GH secretagogue profile
- Popovic V et al. J Clin Endocrinol Metab. — GH secretagogue receptor pathway studies
- National Center for Biotechnology Information (NCBI)
- U.S. Food and Drug Administration (FDA)
- PubChem Compound Summary — CJC-1295 / Ipamorelin
Research Use Only Disclaimer
For Research Use Only (RUO).
This product is intended strictly for laboratory and scientific research purposes. It is not intended for human consumption, veterinary use, cosmetic applications, therapeutic use, or diagnostic purposes.
By purchasing this product, customers acknowledge that they are qualified researchers and agree to use these materials in accordance with all applicable laws and regulations.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Reviews
There are no reviews yet.